VERA insider sale: 16,925 shares reported on Form 144

VERA reported a Form 144 notice showing a sale of 16,925 shares of Common Stock by Marshall Fordyce on 02/23/2026 for $710,577.51.

Rhea-AI Filing Summary

VERA reported a Form 144 notice showing a sale of 16,925 shares of Common Stock by Marshall Fordyce on 02/23/2026 for $710,577.51. The filing also lists 22,951 Restricted Stock Units dated 02/20/2026 as securities to be sold.

The sale is recorded on a Form 144 for Nasdaq-listed shares; the filing lists Morgan Stanley Smith Barney LLC as a broker/dealer contact. No additional proceeds treatment or holder limits are stated in the excerpt.

Insights

Equity Capital Markets Analyst

Routine Form 144 sale by a reporting person; limited market impact evident.

The filing documents a 16,925-share disposition by Marshall Fordyce on 02/23/2026, with proceeds of $710,577.51. This type of Form 144 notice records intended or completed sales of restricted securities under Section 16 rules.

Cash-flow treatment and whether the sale was pre-arranged are not disclosed in the excerpt; subsequent SEC filings or broker reports would show execution details.

Key Figures

Shares sold: 16,925 shares Proceeds reported: $710,577.51 RSUs listed to be sold: 22,951 Restricted Stock Units +2 more

5 metrics

Shares sold 16,925 shares sale date 02/23/2026

Proceeds reported $710,577.51 sale of 16,925 shares on 02/23/2026

RSUs listed to be sold 22,951 Restricted Stock Units dated 02/20/2026 (Securities To Be Sold)

Broker‑Dealer Morgan Stanley Smith Barney LLC listed contact on Form 144

Exchange NASDAQ exchange listed in filing header

Key Terms

Restricted Stock Units, Form 144, Issuer

3 terms

Restricted Stock Units financial

"Securities To Be Sold | 02/20/2026 | Restricted Stock Units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Form 144 regulatory

"CONTENT METADATA: "form_type": "144""

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Issuer regulatory

"Securities To Be Sold | Restricted Stock Units | Issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did VERA's Form 144 disclose about insider sales?

The Form 144 discloses a sale of 16,925 shares by Marshall Fordyce on 02/23/2026. The filing reports proceeds of $710,577.51 and lists 22,951 RSUs dated 02/20/2026 as securities to be sold.

Who executed the broker role in the VERA Form 144 filing?

The broker/dealer listed is Morgan Stanley Smith Barney LLC at New York Plaza. The filing names that firm as the securities contact but does not detail execution methods or settlement timing.

How many Restricted Stock Units does the filing list for potential sale?

The filing lists 22,951 Restricted Stock Units dated 02/20/2026 under 'Securities To Be Sold'. The excerpt does not specify whether those RSUs were previously vested or the exact disposition method.

What proceeds were reported from the insider sale in the Form 144?

The Form 144 reports proceeds of $710,577.51 from the sale of 16,925 shares on 02/23/2026. The filing does not allocate proceeds to issuer receipts or selling‑holder uses in the excerpt.

Does the Form 144 excerpt indicate market impact or trading restrictions?

The excerpt records the sale notice and broker, but it does not state market impact, trading restrictions, or whether sales were under a pre-arranged plan. Execution details are timing- and broker-dependent and not shown here.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/14/2026 - 04:33 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001859453
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Vera Therapeutics, Inc.
SEC File Number	001-40407
Address of Issuer	2000 Sierra Point Parkway, Suite 1200 Brisbane CALIFORNIA 94005
Phone	6507700077
Name of Person for Whose Account the Securities are To Be Sold	MARSHALL FORDYCE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	22951	1003188.21	71355667	04/14/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/20/2026	Restricted Stock Units	Issuer			22951	02/20/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MARSHALL FORDYCE 2000 Sierra Point Parkway, Suite 1200 Brisbane CA 94005	Common	02/23/2026	16925	710577.51

144: Remarks and Signature

Remarks
Date of Notice	04/14/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	01/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Marshall Fordyce
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)